Sophisticated Genomics

Fortuna Genomics employs methods from revolutionary genomics studies to non-invasively assess embryo traits, enabling parents to optimize their children's innate qualities without the need for gene editing.

Reports designed by experts

Genome-wide association studies (GWAS) test hundreds of thousands of genetic variants across millions of genomes to find those statistically associated with a specific trait or disease. This methodology has generated a myriad of robust associations for a range of traits and diseases.

At Fortuna Genomics, our team of ex-MIT researchers uses strategies from groundbreaking peer-reviewed studies to assess the qualities of embryos, allowing soon-to-be parents to non-invasively screen their zygotes for several traits, such as intelligence, athleticism, height, and personality.

SNP rs11076962 is associated with increased intelligence.

SNP rs12150660 is associated with improved fast-twitch muscle fiber size and strength in males and females.

Variation in L3MBTL2 is associated with neuroticism.

Clinical & technological excellence

While genetics and genetic predictions do not always have the final say, many traits have a substantial genetic component which can be maximized. Our models for achieving this are state of the art: the systems we use when analyzing height, for example, can explain 95.3% of the variance in SNP-adjusted height in those with European ancestry.
‍
Armed with comprehensive analyses of the embryos available to a conceiving couple, in-vitro fertilization can be used to bring a selected zygote to term. We partner with the most preeminent IVF clinics to ensure a consistently extraordinary experience made possible by the some of the most proficient physicians in the United States.